Andrew R. Heyer - 12 May 2026 Form 4 Insider Report for biote Corp. (BTMD)

Reporting relationship: Director
Issuer ticker: BTMD
Reported as of: 12 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 May 2026, 16:10:06 UTC
Prior SEC filing: 01 May 2026
Next SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Kendal McNeely, as Attorney-in-Fact for Andrew R. Heyer

Key filing fact

Andrew R. Heyer filed Form 4 for biote Corp. (BTMD) on 14 May 2026.

Key facts

This page summarizes Andrew R. Heyer's Form 4 filing for biote Corp. (BTMD).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 14 May 2026, 16:10.

Change

Previous filing in this sequence was filed on 01 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001259062 Primary reporting owner

HEYER ANDREW R

Relationship: Director
Address: C/O BIOTE CORP., 1875 W. WALNUT HILL LN #100, IRVING
Signature: /s/ Kendal McNeely, as Attorney-in-Fact for Andrew R. Heyer
Signature date: 14 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BTMD transaction Derivative

Deferred Settlement RSU

Award

Transaction value
Shares: +35,259
Change %: +76%
Price: $0.000000^*
Shares after: 81,382
Date: 12 May 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 35,259
Exercise price
Footnotes: F1, F2

BTMD transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +130,000
Change %
Price: $0.000000^*
Shares after: 130,000
Date: 12 May 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 130,000
Exercise price: $2.20
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock.

Footnote F2

The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the date of the Reporting Person's separation from service.

Footnote F3

All shares subject to the option award shall vest on the earlier of May 12, 2027 or the day prior to the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.